Clinical Research Directory
Browse clinical research sites, groups, and studies.
Cerebellum-based Imaging Neural Markers for Antipsychotic Response
Sponsor: Northwell Health
Summary
This study plans to collect 120 patients with first-episode psychosis. Participants will receive multimodal MRI scans (naturalistic fMRI, structural, diffusional) and comprehensive clinical assessments at baseline, and subsequently be treated with either risperidone or aripiprazole for 12 weeks. Clinical assessments for psychotic symptoms will be followed multiple times during the treatment until the 12th week. Data analysis will be conducted at the Psychiatric Research Unit of the Zucker Hillside Hospital.
Official title: Cerebellar-cortical Circuitry and Prediction of Treatment Response in Early Psychosis
Key Details
Gender
All
Age Range
15 Years - 40 Years
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2025-11-01
Completion Date
2030-06-01
Last Updated
2026-05-26
Healthy Volunteers
No
Conditions
Interventions
risperidone
standard treatment, non-randomized
aripiprazole
standard treatment, non-randomized
Locations (1)
Zucker Hillside Hospital
Glen Oaks, New York, United States